Institutional investors purchased a net $4.9 million shares of AEGR during the quarter ended June 2015, and now own 114.98% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTH TIDE CAPITAL LLC Bought 700.0 Thousand shares of Aegerion Pharmaceuticals ...